Lidocaine 18 — Class I drug recall D-0251-2015
Terminated recall by Abrams Royal Pharmacy, reported 2014-11-26, distributed in TX. Non-Sterility
| Recall number | D-0251-2015 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Abrams Royal Pharmacy, Dallas, TX, United States |
| Recall initiated | 2013-04-19 |
| Classified | 2014-11-17 |
| Reported by FDA | 2014-11-26 |
| Terminated | 2016-10-07 |
| Distributed | TX |
| Quantity | 50 syringes |
| Reason classes | sterility |
| Lot numbers | 041013-13 |
| Expiration dates | 2013-06-09 |
Product
Lidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022 mg/mL/Hyaluronidase13.64 u/mL, supplied in 11 mL Sterile Syringes, Rx only, Compounded med, Single use only, (Red Block) ABRAMS ROYAL Compounding Pharmacy, Dallas, TX
Reason for recall
Non-Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0251-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.